These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 7958662)

  • 21. [Drug therapy of hemorrhage in esophageal and gastric varices: role of vasoactive drugs].
    Pulanić R
    Lijec Vjesn; 2000; 122(11-12):276-83. PubMed ID: 11291271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Biphasic effect of phenylalanine- lysine-vasopressin on the lower esophageal sphincter and its significance in the treatment of hemorrhages from esophageal varices].
    Wienbeck M; Bovelet M
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():306-9. PubMed ID: 1088483
    [No Abstract]   [Full Text] [Related]  

  • 23. Octreotide and bleeding oesophageal varices: new indication. Nothing new.
    Prescrire Int; 1999 Aug; 8(42):113-4. PubMed ID: 11503829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Nonsurgical treatment of hemorrhage caused by esophageal varices].
    Fiorucci S; Pelli MA; Farroni F; Clausi GG; Bosso R; Solinas A; Morelli A
    Medicina (Firenze); 1988; 8(1):1-16. PubMed ID: 2906397
    [No Abstract]   [Full Text] [Related]  

  • 25. Terlipressin vs. somatostatin in bleeding esophageal varices: a controlled, double-blind study.
    Walker S; Kreichgauer HP; Bode JC
    Hepatology; 1992 Jun; 15(6):1023-30. PubMed ID: 1350562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination of splanchnic vasoconstrictors and endoscopic band ligation is an effective treatment strategy for acute variceal hemorrhage; but how do we get those drugs approved by the FDA?
    Fortune BE; Groszmann RJ
    Hepatology; 2014 Sep; 60(3):789-91. PubMed ID: 24700393
    [No Abstract]   [Full Text] [Related]  

  • 27. [Drug treatment of acute esophageal varices hemorrhage using vasoactive substances (somatostatin and octreotide)].
    Meier R; Gyr K
    Z Gastroenterol; 1990 Sep; 28 Suppl 2():36-40. PubMed ID: 1980776
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug therapy for portal hypertension.
    Lebrec D
    Gut; 2001 Sep; 49(3):441-2. PubMed ID: 11511569
    [No Abstract]   [Full Text] [Related]  

  • 29. [Strategy for hemostatic treatment of hemorrhages caused by rupture of esophageal and gastric varices].
    Calès P; Oberti F
    Gastroenterol Clin Biol; 1995; 19(5 Pt 2):B1-9. PubMed ID: 8522087
    [No Abstract]   [Full Text] [Related]  

  • 30. No difference in mortality between terlipressin and somatostatin treatments in cirrhotic patients with esophageal variceal bleeding and renal functional impairment.
    Hung TH; Tsai CC; Tseng CW; Tseng KC; Hsieh YH; Tsai CC
    Eur J Gastroenterol Hepatol; 2016 Nov; 28(11):1275-9. PubMed ID: 27455080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Terlipressin acetate].
    Becker PU; Bendtsen F
    Ugeskr Laeger; 1997 Sep; 159(36):5399-402. PubMed ID: 9304275
    [No Abstract]   [Full Text] [Related]  

  • 32. No mortality difference following treatment with terlipressin or somatostatin in cirrhotic patients with gastric variceal hemorrhage.
    Hung TH; Tsai CC; TsenK GC; Hsieh YH; Tseng CW
    Saudi J Gastroenterol; 2016; 22(3):220-5. PubMed ID: 27184641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacology, clinical efficacy and safety of terlipressin in esophageal varices bleeding, septic shock and hepatorenal syndrome.
    Saner FH; Canbay A; Gerken G; Broelsch CE
    Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):207-17. PubMed ID: 19072411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Terlipressin-induced severe left and right ventricular dysfunction in patient presented with upper gastrointestinal bleeding: case report and literature review.
    Elzouki AN; El-Menyar A; Ahmed E; Elbadri ME; Imam YZ; Gurbanna BA
    Am J Emerg Med; 2010 May; 28(4):540.e1-6. PubMed ID: 20466263
    [No Abstract]   [Full Text] [Related]  

  • 35. Development of analogues: successes and failures.
    Bosch J; Lebrec D; Jenkins SA
    Scand J Gastroenterol Suppl; 1998; 226():3-13. PubMed ID: 9595598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Terlipressin-induced metabolic acidosis.
    Foresti V; Parisio E; Ungaro A; De Filippi G; Confalonieri F
    Recenti Prog Med; 1991 Apr; 82(4):240-1. PubMed ID: 1857846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A discussion of how terlipressin limits mortality in cases of bleeding oesophageal varices.
    Lebrec D
    Eur J Gastroenterol Hepatol; 1998 Jul; 10(7):549-52. PubMed ID: 9855076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Somatostatin or its analogs and terlipressin: Different evidence levels, Same recommendations?
    Bai Y; Gao J; Zou DW; Li ZS
    Hepatology; 2008 Apr; 47(4):1428. PubMed ID: 18324692
    [No Abstract]   [Full Text] [Related]  

  • 39. [The effect of vasopressive drugs in managing bleedings from oesophageal varices and the intestinal tract (author's transl)].
    Brieler HS; Thiede A
    Zentralbl Chir; 1979; 104(20):1337-44. PubMed ID: 316950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacologic intervention during the acute bleeding episode.
    Nader A; Grace ND
    Gastrointest Endosc Clin N Am; 1999 Apr; 9(2):287-99. PubMed ID: 10333443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.